OPTIC
A National Resource for Opioid Policy Science
|
 |
Note from the Co-Director
 |
Welcome to the second issue of OPTIC's newsletter. The opioid policy space is both demanding and dynamic, and state and federal policymakers are working rapidly, trying to respond quickly to an ever-evolving crisis. One of the Center's goals is to make sure researchers have the tools they need to help decisionmakers understand which policies work, for whom, and under what circumstances. For example, as part of our efforts to improve opioid policy science, we developed an interactive tool that allows researchers and policymakers to examine how county characteristics are associated with rates of neonatal abstinence syndrome. We will soon offer a simulation tool to assess whether policy studies have adequate statistical power to identify meaningful policy effects and an interactive database that will allow policy makers and researchers to quickly search for opioid policy studies based on type of policy, outcome, or methods used. We welcome your feedback on our efforts at OPTIC@rand.org. – Beth Ann Griffin
|
|
Recent Products from OPTIC Researchers
|
|
|
Photo by Kwangmoozaa/Getty Images
|
|
Opioid-exposed newborns are more likely in counties with high rates of long-term unemployment and few mental health services. An interactive tool created by Vanderbilt University and the RAND Corporation explores how these factors affect rates of neonatal abstinence syndrome over time.
Read more »
|
|
|
|
Photo by bkindler/Getty Images
|
|
The growing use of medication treatment for opioid use disorder in the West Virginia Medicaid expansion population provides an opportunity to reduce overdose deaths.
Read more »
|
|
|
|
Photo by Adrees Latif/Reuters
|
|
States that adopted naloxone access laws giving direct prescription authority to pharmacists had significant decreases in opioid-related deaths. Other types of naloxone access laws did not seem to affect opioid overdose rates.
Read more »
|
|
|
|
Photo by Nadasaki/Getty Images
|
|
Policies establishing thresholds for morphine equivalent daily dose (MEDD) prescribing are a promising policy tool, but there is no consensus about how the thresholds should be used and what the threshold level should be. This work provides a foundation for future evaluation of MEDD policies and may inform states considering adopting such policies.
Read more »
|
|
|
|
For individuals diagnosed with opioid use disorder
BUPRENORPHINE
PRESCRIBING
more than doubled
in West Virginia's Medicaid expansion under the Affordable Care Act. (RAND Corporation)
|
|
|
|
National Perspectives
|
|
A national sampling of thought-provoking research and insights
|
|
|
Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality: An Audit Study - Beetham, T., Saloner, B., Wakeman, S.E., Gaye, M., Barnett, M.L. Annals of Internal Medicine
Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids - Chua, K. P., Brummett, C. M., Conti, R. M., Haffajee, R. L., Prosser, L. A., & Bohnert, A. S. JAMA Network Open
Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017 - Clemans-Cope, L., Lynch, V., Epstein, M., & Kenney, G. M. The Annals of Family Medicine.
Use of Opioid Overdose Deaths Reported in One State’s Criminal Justice, Hospital, and Prescription Databases to Identify Risk of Opioid Fatalities - Eisenberg, M. D., Saloner, B., Krawczyk, N., Ferris, L., Schneider, K. E., Lyons, B. C., & Weiner, J. P. JAMA Internal Medicine
Trends in opioid prescribing for adolescents and young adults in ambulatory care settings - Hudgins, J. D., Porter, J. J., Monuteaux, M. C., & Bourgeois, F. T. Pediatrics
Buprenorphine Treatment Divide by Race/Ethnicity and Payment - Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T. JAMA Psychiatry
Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions - Lo-Ciganic W, Huang JL, Zhang HH, et al. JAMA Network Open
The Affordable Care Act and opioid agonist therapy for opioid use disorder - Mojtabai, R., Mauro, C., Wall, M. M., Barry, C. L., & Olfson, M. Psychiatric Services
Contemporary Asian Drug Policy: Insights and Opportunities for Change - Pardo, B., Kilmer, B. & Huang, W. RAND Corporation
NGA Issue Bulletin: Emerging Trends in the Evolving Opioid Overdose Epidemic - Simonsen, E.T. & Hill, K. National Governors Association
Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision - Wettstein, G. Health Economics
Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017 - Zhu, W., Chernew, M. E., Sherry, T. B., & Maestas, N. New England Journal of Medicine
|
|
Forthcoming Presentations
|
|
|
June 25, 2019
Emerging Issues in the Evaluation of Opioid Policies session featuring three papers: Problems in Defining and Evaluating State Opioid Policies: Insights from RAND's OPTIC Center, The Dynamics of Local Opioid Markets and Their Response to State Policies, and The State of the Statistical Science for Evaluating Opioid Policies: Findings from Simulations at the American Society of Health Economists Annual Conference (ASHEcon), Washington, D.C. - Rosalie Pacula, Rosanna Smart, and David Powell
Sept 5, 2019
Keynote address at International Society of Addiction Journal Editors (ISAJE), Banff, British Columbia - Rosalie Pacula
October 16, 2019
Providing statistical methods preconference courses and presenting at Addictions Health Services Research (AHSR), Park City, UT - Beth Ann Griffin, Rosalie Pacula, Rosanna Smart, Bradley Stein and David Powell
November 7, 2019
Presenting at Association for Public Policy Analysis and Management (APPAM), Denver, CO - Rosanna Smart
November 13 - 16, 2019
Presenting new insights about fentanyl markets & harm reduction at American Society of Criminology (ASC), San Francisco, CA - Rosanna Smart and Bryce Pardo
|
|
|
|
|
|
OPTIC is designed to be a national resource, fostering innovative and high-quality research in opioid policy science, and developing and disseminating methods, tools, and information to the research community, policymakers, and other stakeholders.
http://www.rand.org/OPTIC
|
|
|
|
Privacy statement | Unsubscribe
|
 |
RAND Corporation. 1776 Main Street, Santa Monica, CA 90401-3208.
RAND® is a registered trademark.
|
|
|
|
|
.png)
